Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous retinoid absorption and embryotoxicity.

C C Willhite1, R P Sharma, P V Allen

  • 1Department of Health Services, State of California, Berkeley.

The Journal of Investigative Dermatology
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposures in early life: associations with DNA promoter methylation in breast tumors.

Journal of developmental origins of health and disease·2014
Same author

Development and usability testing of a web-based cancer symptom and quality-of-life support intervention.

Health informatics journal·2014
Same author

Seed germination and growth inhibitory cadinenes fromEupatorium adenophorum spreng.

Journal of chemical ecology·2013
Same author

Cytotoxicity of Fusarium T-2 in cultured Madin-Darby bovine kidney (MDBK) and primary fetal bovine kidney (PFBK) cells.

Mycotoxin research·2013
Same author

Functional alterations induced by fusarium T-2 toxin in Madin-Darby bovine Kidney (MDBK) and primary fetal bovine Kidney (PFBK) cultures.

Mycotoxin research·2013
Same author

Effects of T-2 toxin and its congeners on membrane functions of cultured human fibroblasts.

Mycotoxin research·2013

Topical retinoid application showed rapid skin absorption but limited systemic exposure. Skin toxicity, not teratogenicity, was the primary concern, influencing embryo exposure and bioassay interpretation.

Area of Science:

  • Pharmacology
  • Toxicology
  • Developmental Biology

Background:

  • Topical retinoids are used for various skin conditions.
  • Understanding their absorption, distribution, metabolism, and excretion (ADME) is crucial for efficacy and safety.
  • Assessing the risk of teratogenicity from topical application requires careful consideration of systemic exposure.

Purpose of the Study:

  • To investigate the pharmacokinetics and toxicological effects of topical all-trans-retinoic acid and related compounds in hamsters.
  • To compare systemic absorption and teratogenic potential of topical versus oral retinoid administration.
  • To evaluate the role of skin toxicity in limiting systemic retinoid exposure and embryo risk.

Main Methods:

  • Single and multiple topical applications of all-trans-retinoic acid, etretinate, and arotinoid Ro 13-6298 to hamster skin.

Related Experiment Videos

  • Radioactive labeling ([3H2]-all-trans-retinoic acid) to track absorption and elimination.
  • Pharmacokinetic modeling (two-compartment open model) to describe plasma concentrations.
  • Assessment of local skin reactions (erythema, hyperplasia) and systemic teratogenic effects (malformations, embryo death).
  • Main Results:

    • Rapid absorption and dose-dependent elimination of topical all-trans-retinoic acid from hamster skin.
    • Unchanged all-trans-retinoic acid was a minor fraction of circulating radioactivity; prolonged skin absorption contributed to high bioavailability.
    • Topical doses caused local skin toxicity (erythema, hyperplasia) but not significant teratogenicity.
    • Arotinoid Ro 13-6298 caused dose-dependent mucocutaneous toxicity and increased embryo/offspring abnormalities.
    • Skin toxicity limited systemic absorption and embryo exposure, suggesting it's a critical factor in teratogenicity bioassays.

    Conclusions:

    • Skin toxicity is a major determinant of systemic retinoid exposure following topical application.
    • Comparing absorbed systemic doses, rather than applied topical doses, is essential for interpreting retinoid teratogenicity bioassays.
    • Skin toxicity may limit the amount of retinoid reaching the embryo in humans, while in rodents, it could potentially increase penetration under certain conditions.